Essais liés7clinical trials
VilleWuhanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05066217

Ouvrir le site du centre

Essais cliniques associés

7
MoléculeIndication / populationPhaseNCTTitreStatut
Clemizole HCl Épilepsie Phase 3 NCT05066217 An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome RECRUITING
Rimegepant Migraine Phase 3 NCT06616194 A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine ACTIVE_NOT_RECRUITING
zorevunersen Épilepsie Phase 3 NCT06872125 A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome RECRUITING
LP352 Épilepsie Phase 3 NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) RECRUITING
LP352 Épilepsie Phase 3 NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) ACTIVE_NOT_RECRUITING
LP352 Épilepsie Phase 3 NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) ENROLLING_BY_INVITATION
Rimegepant/BHV3000 Migraine Phase 3 NCT04649242 Randomized Study in Children and Adolescents With Migraine: Acute Treatment RECRUITING